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Abstract: The fecal microbiota plays an important role in human health, and alterations in the
microbiota–host interaction seem to be involved in the ageing process. Therefore, it is of interest to
develop strategies for promoting a balanced microbiota in old age in order to prevent the physiological
and immune decline associated with age. However, the specific microbiota changes in the transition
from adulthood to senescence are not yet well understood. Here we assessed the levels of some
intestinal microorganisms and short chain fatty acids (SCFAs) across different age-groups. In total,
153 adults from four age groups (<50, 50–65, 66–80, and >80 years-old) were recruited; the levels of
different bacterial groups in fecal samples were determined by quantitative polymerase chain reaction
(qPCR), and those of SCFA by gas chromatography. Dietary information was collected by using
a Food Frequency Questionnaire. The presence of the Bifidobacterium, Faecalibacterium, Bacteroides
group, and Clostridium cluster XIVa decreased with age up to 66–80 years of age, with differences
reaching statistical significance for the latter group. Interestingly, the levels of some of these
microorganisms recovered in the very old age group (>80 years), with these older individuals
presenting significantly higher counts of Akkermansia and Lactobacillus group than adults and the
younger elderly. In addition, ageing was associated with a progressively and statistically significant
reduction in the fecal concentrations of SCFAs. Dietary intakes also showed some statistically
significant differences among the groups for some macro- and micronutrients. Moreover, associations
of some microorganisms with age and macronutrients were also evidenced. Considering the role that
fecal microbiota alterations may have in terms of impairing homeostasis and resilience, our results
underline the importance of understanding the ageing and immunosenescence processes by including
the microbiota perspective.
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1. Introduction
The gastrointestinal tract is home to a myriad of microbes, constituting the so called “intestinal
microbiota” which is critical for health maintenance [1]. The adults’ microbiota is dominated by
the phyla Bacteroidetes and Firmicutes, whilst Actinobacteria, Proteobacteria, and Verrucomicrobia
are represented in lower percentages [2]. In addition to bacterial and eukaryotic cells, the main
representative of Archaea in the adult gut is the methanogenic species Methanobrevibacter smithii [3].
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Some alterations in the composition of this microbiota are linked to an increased risk of different diseases
during both infancy and adulthood [1]. During adult life, in the absence of external disturbances,
the fecal microbiota is relatively stable, but an altered composition has been repeatedly reported
in elderly subjects [4]. This has attracted the interest of researchers with respect to the potential role
of the microbiota in the ageing process and the possibilities for its modulation, given the growing
proportion of elderly subjects in modern societies [5]. Extending the period of good health in seniors,
with the concomitant reduction of the ageing-associated health-care costs, is a pending task and one of
our main current societal challenges. Unfortunately, our understanding of the intestinal microbiota
(IM) changes along ageing is still limited; therefore, improving our knowledge on the transition from
adulthood to old age is essential for developing IM-targeted strategies for promoting healthy ageing.
Different studies have reported an alteration in the fecal microbiota composition in the elderly [6–10].
In this way, reduced levels of Bacteroides and Clostridium cluster XIVa have been repeatedly observed [6,10–12].
Similarly, important intestinal microorganisms, such as Faecalibacterium prausnitzii and Bifidobacterium, have
also been found at lower levels in elderly subjects whereas others, such as Akkermansia, have been reported
to be increased [10,13,14]. These age-related changes in the composition of the IM lead to a reduction
in the intestinal levels of short chain fatty acids (SCFAs) [10]. Moreover, the immunity has also been
repeatedly reported to be affected by ageing with a pro-inflammatory state and with increased levels of
pro-inflammatory cytokines often present in elderly subjects [10,15]. These two aspects of ageing, microbiota
and immune changes, are very likely related. On one hand, this inflammation may produce reactive
oxygen species and, thus, a more oxidative intestinal environment with a concomitant decrease in strict
anaerobes and an increase of facultative microorganisms. However, on the other hand, the intestinal
microorganisms may also reduce the intestinal environment limiting these reactive species and therefore
reducing inflammation.
Interestingly, studies on extremely old subjects (centenarians) do not fully support the above
mentioned age-associated alterations in the microbiota and immunity. This points out at a microbiota
remodeling in very old individuals that may be different to that occurring in younger elder subjects [7,16].
These data suggest that extremely old people may have a specific IM profile, distinct from that of elders
not living so long, allowing the extremely old to postpone major age-related conditions [17]. However,
it should be noted that this delay in the appearance of health problems and the altered microbiota
pattern are very likely influenced by the dietary and health habits in these long-living individuals [18].
In this regard, as previously stated, several functions are affected in elderly people, including the
immune system and the microbiota, but the dietary habits are also different from those of younger
adults [10]. Although the nutritional requirements of active elderly subjects may be similar to those of
adults, their ability to absorb nutrients may be hampered, the appetite may be reduced, and chewing
difficulties may be present, often resulting in a poor nutritional status.
Therefore, the potential changes in the fecal microbiota composition and, more specifically, in the
microbiota–diet interaction associated with ageing constitute a research area of great interest. Most of
the studies on this area have compared elderly subjects with control groups composed of young
adults, but there are limited data focusing specifically on the transition from adulthood to old age.
Understanding this transition will allow the development of intervention strategies targeted at mature
adults or young elderly, aiming at promoting healthy ageing. In this context, here we aimed at
characterizing the levels of the main intestinal microorganisms, SCFAs, and nutritional habits in four
different age groups ranging from adults (<50 years of age) to elderly of advanced age (>80 years
of age).
2. Materials and Methods
2.1. Volunteers and Samples
The study sample included 153 adults who were categorized into four age groups: <50 (n = 49),
50–65 (n = 58), 66–80 (n = 19), and >80 (n = 27) years. All volunteers were recruited in the central area
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of the Asturias Region (northern Spain). Exclusion criteria were previous diagnosis of gastrointestinal
cancer, autoimmune diseases, digestive diseases or morbid obesity, and consumption of probiotics,
prebiotics, or antibiotics during the previous month (Supplementary Table S1). Fecal samples were
collected, immediately frozen and transported to the laboratory for microbiota analyses. At the
laboratory, fecal samples were melted, homogenized (1:10 w/v) in phosphate-buffered saline (PBS),
and the DNA and fecal supernatants were obtained as previously described [19]. Purified DNA and
fecal supernatants were stored at −20 ◦C until analyses. The study was approved by the Regional
Ethical Committee of Asturias Public Health Service and the Ethical Committee of CSIC; informed
written consent was obtained from all volunteers participating in the study.
2.2. Quantification of Fecal Microbiota Groups by Quantitative Polymerase Chain Reaction (q PCR)
Previously described primers and conditions [20] were used for quantification of the different
bacterial populations analyzed (Akkermansia, Bacteroides group, Bifidobacterium, Clostridium cluster XIVa,
Lactobacillus group, and Faecalibacterium). qPCR reactions were performed in a 7500 Fast Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA) using SYBR Green chemistry (Applied Biosystems).
Bacterial levels were determined by including standard curves made with pure cultures of appropriate
strains. Samples were analyzed in duplicate in at least two independent PCR runs. Bacterial levels
were calculated as the log of the number of cells per gram of feces.
2.3. Analysis of SCFAs in Feces by Gas Chromatography-Mass Spectrometry/Flame Injection Detector (MS/FID)
For SCFA determination filtered (0.2-µm pore-size filters) fecal supernatants were submitted to
gas chromatography in a chromatographic system, composed of a 6890NGC module with an FID and
a MS 5973N detector (Agilent Technologies. Inc, santa Clara, CA, USA), as previously described [21].
2.4. Nutritional Assessment
Dietary intake was assessed by a personal interview for filling a validated semi-quantitative
annual Food Frequency Questionnaire (FFQ) as described elsewhere [22]. In brief, the volunteers
were interviewed by a trained dietician in an item-by-item manner whether they usually ate each
food and, if so, how much they usually ate (three different serving sizes of each cooked food
were presented in pictures) and about their cooking habits. Food intake was analyzed for energy,
macronutrients, and fiber by using the nutrient Food Composition Tables developed by the Centre for
Higher Studies in Nutrition and Dietetics (CESNID) [23] and for the consumption of polyphenols by
using the Phenol-explorer Database [24]. The weight and height were recorded following standardized
methods and the data were used to calculate the body mass index (BMI) through the formula
weight (kg)/height (m2).
2.5. Statistical Analyses
Analysis of varianza (ANOVA), followed by post-hoc (Bonferroni test) analyses, was conducted for
comparingthedifferentmicrobiologicalvariablesanalyzedamongthe fouragegroups. Differences, according
to age groups, were estimated by multivariate analysis of variance including gender, BMI, and energy as
covariates. When significant effects were observed the Bonferroni test was used for inter-groups comparison.
Pearson correlation test was used for assessing associations between age/macronutrients and microbiota as
continuous variables. Differences in the proportions of categorical variables were assessed by chi-square
test. Analyses were performed with R software (version 3.3.3, The R Foundation, Vienna, Austria) and the
conventional p-level of 0.05 was used in the interpretation of results.
3. Results
The general characteristics of the individuals according to age-groups included in this study
are shown in Table 1. Regarding the fecal microbiota composition (Figure 1), the Bacteroides group
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was the dominant among the bacteria analyzed in all age groups, with levels ranging between
6.9 ± 3.7 log cells/g feces (mean ± SD) for subjects of 66–80 years and 8.8 ± 0.7 log cells/g feces
(mean ± SD) in the oldest individuals (over 80 years of age). When the levels of these microorganisms
were compared among the different age groups (Figure 1), the oldest group (>80 years of age) was
found to harbor significantly higher levels of Akkermansia and Lactobacillus-group than the younger
age groups. In addition, significantly lower levels of Clostridium cluster XIVa were found in the group
aged 66–80 years as compared with the younger (50–65 years) adult group. No other statistically
significant differences where observed, likely due to the large inter-individual variability. Nevertheless,
it is worth mentioning that the levels of the Bifidobacterium, Faecalibacterium, and Bacteroides groups
were lower with increasing age of the different population groups up to the group aged 66–80 years,
but surprisingly, this was not the case in the very old age group (>80) for which the levels of all these
microorganisms, with the only exception of Faecalibacterium, were higher as compared with elderly
subjects of 66–80 years of age.
Table 1. General characteristics of subjects according to age groups.
Variables
Age Group (Years)
<50 (n = 49) 50–65 (n = 58) 66–80 (n = 19) >80 (n = 27)
Female (%) 65.3 69.0 78.9 77.8
Age 37.6 ± 6.4 58.1 ± 4.0 72.8 ± 5.2 85.7 ± 4.4
BMI (kg/m2) 27.89 ± 5.21 a 25.64 ± 3.19 b 29.69 ± 4.31 a 28.33 ± 3.98 a,b
Results are presented as mean ± SD. Differences in categorical variables were examined using chi-squared analysis
and are presented as a percentage (%). BMI: body mass index. The values of the same row not sharing the same
superscript are significantly different, p < 0.05.
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statistically significant differences (p < 0.05) among the indicated age groups. 
As expected, acetate was the major SCFA in the feces of all volunteers, followed by propionate 
and butyrate. The fecal concentration of SCFAs decreased along the age groups (Table 2). In contrast 
with that evidenced for the quantification of the different microbial groups, the concentration of the 
main SCFAs decreased with the increase of age, with the very old age group presenting the lowest 
fecal concentration of these compounds. This led to significantly (p < 0.05) lower levels of total SCFAs 
and individual SCFAs analyzed in the oldest group (>80 years of age) as compared with the young 
adult group (<50 years of age) (Table 2).  
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Figure 1. Bacterial levels (log cells/g, estimated marginal mean ± SD) of the microbial groups analyzed
in the different age groups. Result wer adjuste energy intake, g nder and BMI. * Denotes
statistically significant differenc s (p < 0.05) among th i icated age groups.
As expected, acetate was the major SCFA in the feces of all volunteers, followed by propionate
and butyrate. The fecal concentration of SCFAs decreased along the age groups (Table 2). In contrast
with that evidenced for the quantification of the different microbial groups, the concentration of the
main SCFAs decr ased with the increase of age, with the very old age group presenting the lowest
fecal concentration of these compounds. This led t significantly (p < 0.05) lower levels of total SCFAs
and individual SCFAs analyzed in the oldest group (>80 years of age) as compared with the young
adult group (<50 years of age) (Table 2).
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Table 2. Concentration (mM; estimated marginal mean ± SD) of acetate, propionate, butyrate and total
short chain fatty acids (SCFAs) (acetate + propionate + butyrate) in fecal samples from volunteers of
the different age groups.
SCFA
Age Group (Years)
<50 50–65 66–80 >80
Acetate 49.4 ± 18.3 a 32.9 ± 14.7 b 31.6 ± 17.7 bc 18.8 ± 11.4 c
Propionate 16.0 ± 7.8 a 12.6 ± 5.9 ab 12.1 ± 8.1 ab 8.1 ± 6.8 b
Butyrate 10.9 ± 5.3 a 10.4 ± 8.1 ab 12.1 ± 8.3 ab 6.3 ± 6.4 b
TOTAL 76.4 ± 27.9 a 56.0 ± 25.4 b 55.8 ± 32.3 bc 32.3 ± 24.1 c
Results were adjusted by energy intake, gender, and BMI. Groups showing different superscript letters differ
significantly (p < 0.05)
Regarding nutritional habits and dietary intake, subjects between 66–80 years of age had
a significantly (p < 0.05) lower energy intake than those in the 50–65 year old group (1624 ± 435 vs.
2033 ± 512 kcal/day, respectively), these two groups not differing significantly from those younger
than 50 years (1922 ± 575 kcal/day) or over 80 years of age (1728 ± 400 Kcal/day). Due to this difference
in energy intake this variable was used as a covariate, together with gender and BMI, for further
analysis. As could be expected, differences in the intake of the major food groups and nutrients, some
of them with influence on the immune system, were also observed among the age groups. Considering
food categories, the intake of sugar and sugary products, vegetables, potatoes, fruit, fish and seafood
and non-alcoholic drinks varied among the groups of age (Table 3). Consequently, fiber intake and
lipid profile also showed differences among age groups. The intake of saturated and polyunsaturated
fatty acids was higher in the groups of elderly over 80 years of age, whereas no differences between the
extreme groups were observed for fiber intake. No other differences in macronutrients intake were
observed among the analyzed age groups. However, regarding the micronutrients and compounds
evaluated for their relationship with the immune system, differences among age groups were observed
for the intake of carotenes, folic acid, vitamin A, vitamin C, vitamin D, vitamin B6, and polyphenols,
the intakes being, in general, lower in the oldest group.
The correlation analyses performed between microbial groups and age showed a significant
(p < 0.05) and positive correlation of age with levels of Akkermansia and lactobacilli, and a negative
correlation (p < 0.05) with those of Faecalibacterium (Figure 2). As expected from microbial data,
significant correlations (p < 0.05) between age and the fecal levels of SCFAs were also observed,
in all cases being of negative sign and significant for the three major SCFAs. With regard to
macronutrient–microbiota correlations, the intake of polyunsaturated fatty acids (PUFAs) correlated
(p < 0.05) negatively with the levels of Bacteroides group, whereas consumption of vitamins B6 and C
showed a statistically significant (p < 0.05) positive correlation with the levels of this microbial group
(Figure 2). Similarly, polyphenols intake was positively correlated with the levels of Bacteroides and
Clostridium cluster XIVa. On the contrary intake of vitamins A and D showed a statistically significant
(p < 0.05) negative correlation with Lactobacillus group. Given that the origin of SCFAs in the colon
is mainly the microbial fermentation of complex carbohydrates, it is not surprising that the levels of
SCFAs, especially of butyrate and propionate, showed a positive association with the intake of fiber
(either soluble or insoluble) and polyphenols. In this regard, it must be pointed out that polyphenols
and fiber share their main food sources and, therefore, it is frequent to find common associations to
both groups of compounds [21].
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4. Discussion
In general, the intestinal bacterial levels determined in this study are within the range of those
previously reported by us and other authors for similar human groups of age [6,10,25]. Although
our study does not provide a complete microbiota characterization, such as that obtained by using
Next-Generation Techniques (NGS) techniques, it does provide truly quantitative data instead of relative
proportions, sheddi g additional light on the age group comparisons conducted. Moreove , our results
confirm the ageing-related ecline n he levels of some icroorganisms such as the Bacteroides
group, Bifidobacterium, Faecalibacterium, or Clostridium cluster XIVa previously reported [6,10–12,26,27].
This holds true for the group of elderly between 66 and 80 years of age, which matched the age range of
human populations participating in most of the studies cited formerly, but strikingly, it is not true for
the oldest subjects (over 80 years of age). In fact, the oldest group in our study showed higher levels of
all the microorganisms analyzed, with the exception of Faecalibacterium, than the elders between 66
and 80 years, with these differences reaching statistical significance for Akkermansia and Lactobacillus.
This suggests, in accordance with other authors [7,16,28], that very long-living individuals present
a microbiota profile distinct from that of lderly subjec s not living so long. The data rep rted by other
authors, together with our observations, point out at the p tential association f the presence of high
levels of some of these microorganis s, such as Akkermansia, with a longer survival [29].
Moreover, our data on the comparison of the elderly (group aged 66–80 years) with those
over 80 shed some light on the apparent lack of agreement between studies in elderly subjects.
Apparently contradictory results have been previously reported for some of the fecal microbiota
groups analyzed, such as Akkermansia [6,30] or lactobacilli [10,11,31], among others. To this regard the
different methodologies used among the studies may have an effect. Nevertheless, on the view of our
results, the age of the elderly groups participating in the different studies should be also considered as
an important factor of variation, si ce differences among them are appare reover, although the
different studies published, like this one, have d fined inclusion crit it is not always possible to
ascertain the lack of effects due to treatments or conditions that were present in the life of the individual
before running in the study.
Contrary to that expected from the microbiota data, the levels of SCFAs showed a continued
age-associated reduction, with the oldest age group (subjects over 80 years of age) displaying SCFA
levels that were less than half of those found in younger adults (<50 years old). This reduction in the
amount of SCFAs found by us in elderly subjects confirms previous observations [10,31]. Given the
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important role played by the intestinal SCFAs [32] this reduction on the levels of these compounds
during ageing may have profound consequences in terms of gut barrier maintenance and host
physiological homeostasis. Interestingly, this differential trend of microbial levels and concentration of
microbial metabolites in subjects over 80 years of age, suggests that, despite bacterial levels remaining
high, there is a drop in the metabolic activity of the microbiota in these very old subjects. However, it is
also important to underline that the SCFA fecal levels may also be influenced by other factors such as
the the carbon sources available from diet or the absorption/excretion of these metabolites, which may
also be affected in subjects of advanced age.
Table 3. Mean daily intake of the major food categories and nutritional compounds related with
immune function, according to age.
Age Group (Years)
<50 50–65 66–80 >80
Energy (kcal/day) # Food groups (g) 1922 ± 575 a,b 2033 ± 581 a 1624 ± 435 b 1728 ± 400 a,b
Cereals 176.3 ± 9.7 a 185.0 ± 9.0 a 143.9 ± 15.8 a 153.5 ± 13.4 a
Dairy products 311.7 ± 29.8 a 396.7 ± 27.7 a 410.8 ± 48.6 a 408.0 ± 41.3 a
Fats and oils 25.2 ± 2.4 a 30.1 ± 2.2 a 23.8 ± 3.9 a 24.0 ± 3.3 a
Sugar/sugary products ** 29.7 ± 2.8 a 11.0 ± 2.6 b 13.8 ± 4.6 b 11.2 ± 3.9 b
Vegetables * 157.6 ± 19.0 a,b 205.2 ± 17.6a 164.0 ± 31.0 a,b 105.1 ± 26.2 b
Potatoes ** 45.8 ± 6.8 a,b 43.1 ± 6.3 a 69.8 ± 11.3 b 68.6 ± 9.4 a,b
Legumes 28.7 ± 12.4 a 37.8 ± 11.5 a 27.5 ± 20.1 a 21.5 ± 17.1 a
Fruit ** 193.8 ± 27.6 a 343.9 ± 25.6 b 271.4 ± 45.0 a,b 205.2 ± 38.2 a
Meat and derivate 134.8 ± 7.9 a 115.5 ± 7.3 a 110.9 ± 12.9 a 122.9 ± 10.9 a
Fish and derivate ** 42.2 ± 5.5 a 60.7 ± 5.1 a,b 88.2 ± 8.9 b 89.1 ± 7.6 b
Non-alcoholic drinks ** 307.3 ± 27.6 a 167.3 ± 25.7 b 182.8 ± 45.0 b 145.0 ± 38.2 b
Dietary components
Carbohydrates (g) 206.9 ± 4.9 a 199.2 ± 4.6 a 196.8 ± 8.1 a 188.9 ± 6.8 a
Total fiber ** 17.5 ± 0.7 a 22.1 ± 0.7 b 19.3 ± 1.2 a 17.5 ± 1.0 a
Insoluble fiber ** 11.6 ± 5.6 a 14.3 ± 5.4 b 12.4 ± 4.0 a,b 10.2 ± 3.8 a
Soluble fiber ** 2.1 ± 0.8 a 2.9 ± 1.3 b 2.6 ± 0.8 a,b 2.1 ± 0.9 a
Proteins (g) 83.8 ± 2.5 a 89.6 ± 2.3 a 89.7 ± 4.0 a 90.9 ± 3.4 a
Animal 55.3 ± 2.5 a 58.6 ± 2.3 a 59.9 ± 4.0 a 61.1 ± 3.4 a
Vegetal 25.0 ± 1.1 a 29.2 ± 1.0 a 27.6 ± 1.8 a 27.9 ± 1.6 a
Lipids (g) 78.3 ± 2.1 a 78.3 ± 2.0 a 79.2 ± 3.5 a 85.4 ± 3.0 a
SFAs ** 24.8 ± 1.0 a 25.1 ± 0.9 a 28.0 ± 1.6 a,b 30.4 ± 1.4 b
MUFAs ** 31.0 ± 1.4 a,b 34.9 ± 1.3 a 28.9 ± 2.3 b 28.5 ± 2.0 b
PUFAs ** 16.1 ± 1.0 a,b 11.9 ± 0.9 a 15.7 ± 1.7 a,b 19.6 ± 1.4 b
Vitamins
Carotenes (µg) ** 2048 ± 1583 a 2464 ± 1821 a 1899 ± 2278 a,b 1014 ± 315 b
Folic acid (µg) ** 308.3± 128.1 a 390.8 ± 177.6 b 330.3 ± 128.4 a 275.3 ± 82.64 a
Vitamin A (µg) ** 822.2 ± 477.8 a 743.2 ± 435.5 a 619.7 ± 425.3 b 430.7 ± 129.8 b
Vitamin B12 (µg) 7.7 ± 7.0 a 7.1 ± 4.3 a 8.2 ± 3.1 a 8.7 ± 2.6 a
Vitamin B6 (mg) ** 1.9 ± 0.7 a 2.2 ± 0.7 b 2.1 ± 0.6 a,b 1.8 ± 0.4 a
Vitamin C (mg) ** 123.7 ± 72.2 a 199.6 ± 165.2 b 187.2 ± 97.2 a,b 155.2 ± 74.8 a
Vitamin D (µg) ** 2.8 ± 1.9 a 3.8 ± 2.6 b 1.7 ± 1.7 a,c 0.8 ± 0.3 c
Vitamin E (mg) ** 12.7 ± 6.8 a 10.5 ± 5.0 a 12.1 ± 5.1 a 13.7 ± 5.5 a
Minerals
Copper (mg) 1.4 ± 0.7 a 1.3 ± 0.5 a 1.3 ± 0.4 a 1.1± 0.3 a
Iron (mg) 12.2 ± 5.2 a 12.8 ± 3.9 a 13.2 ± 3.7 a 12.6 ± 2.7 a
Selenium (µg) * 118.9 ± 52.8 a 122.0 ± 42.4 a 136.5 ± 38.3 a 137.6 ± 33.9 a
Total polyphenols (mg) ** 1202 ± 651 a 1721 ± 938 b 1265 ± 1324 a 841 ± 658 a
Results derived from multivariate analysis adjusted by energy intake, gender and BMI (Asterisks denotes variables
showing statistically significant effects (* p < 0.05; ** p < 0.01) on the multivariate model). # Unadjusted
univariate model. Variables are presented as estimated marginal mean ± sd. SFAs, saturated fatty acids. MUFAs,
monounsaturated fatty acids. PUFAs, polyunsaturated fatty acids. Groups showing different superscript letters
differ significantly (p < 0.05; Bonferroni’s test).
Our results also suggest potential associations between nutrient intake and the gut microbiota.
In accordance with that previously reported [33] fiber associated positively with SCFA levels,
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whereas the polyphenols, compounds known to promote an appropriate immune status [34], correlated
with the levels of some microorganisms. Some differences in fiber intake, including soluble fiber,
are apparent among age groups; however, these are within a narrow range, which together with the
lack of correlation observed between fiber and microbial groups in the correlation analyses suggest that
the variation in fiber intake does not have a major role in the observed differences. In this regard, it is
important to take into consideration that some dietary polyphenols cannot just be metabolized by the
microbiota but they can affect the microbiota composition [35], even modulating some bacterial groups
with a non-negligible role in the host immune system. Therefore, another aspect that is of great relevance
in this sort of study is the potential impact of nutritional differences in the observed effects. Our data,
in agreement with previous reports [9,10], show significant differences in dietary habits and, therefore,
nutritional status among the analyzed age groups. In this sense it is also important to aknowledge that,
although we do not think this has a significant effect in our results, a certain recall bias in relation to
age, affecting the accuracy of the dietary information collected, may be present. Taking into account
that distinct population groups, such as the elderly, may have different nutritional needs, the potential
influence of such differences may not be neglected. Despite malnutrition in the elderly being linked with
frailty and an increased risk of disease, this situation does not seem to be extrapolable to our sample,
where the intake of macronutrients is similar across age groups and is sufficient to satisfy the nutritional
requirements of each life stage [36,37]. However, some micronutrients and bioactive compounds are
crucial for the maintenance of immunocompetence [38]. At this point, it is noteworthy that the group
of subjects aged >80 years-old presented mineral intakes comparable to the younger groups (including
iron, for which intake was above the recommended 8 mg/day for this age group), and even higher daily
intakes of vitamins B12 and E as compared the rest of the groups. Nevertheless, the detection, in the
group of people over 80 years of age, of a lower intake of some micronutrients with well documented
roles in promoting immune function in the elderly, such as carotenoids, folic acid, and vitamins
A and D, may be considered in future studies aiming to prevent/minimize immunosenescense by
means of specific nutritional supplementation [4,39]. Also, polyphenols could play an additional key
role in the complex bidirectional relationship between diet and immunity by means of microbiota
modulation throughout life. Therefore, nutritional assessment and monitoring represent a key aspect
when studying the age-associated changes in gut microbiota composition, and also in other aspects
such as immune senescence. Such multifactorial approach promises to allow the development of
nutritional strategies to positively modulate the fecal microbiota and immune system and to reduce
nutritional deficiencies in the elderly. It is important, however, to underline that cross-sectional studies,
like this one, present some limitations for the monitoring the shifts in the fecal microbiota along the
lifespan. They may carry over important cohort effects and, while useful for understanding some
phenomena and drawing hypotheses, validation from longitudinal studies is often needed.
5. Conclusions
Our results provide evidence on ageing-related changes in the composition and metabolic
activity of the fecal microbiota as potentially beneficial for healthy ageing, signaling that specific
microorganisms are linked to a long life span. Dietary changes are also present, which makes it difficult
to discriminate microbiota changes attributed to ageing from those that could be a consequence of
dietary or physiological modifications. In this context, it is important to understand the interaction
between gut microbiota, diet, and ageing, since this knowledge promises to expand our possibilities
for the development of diets and foods in order to promote healthy ageing.
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